Mandibular Reconstruction With Axially Vascularised Bone Substitutes

Mandibular Deficiency Clinical Trial

Official title:

Mandibular Reconstruction Using Tissue Regeneration With Axially Vascularised Bone Substitutes

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04001842
• Other study ID #: 040215
• Status: Recruiting
• Phase: N/A
• Start date: July 1, 2019
• Est. completion date: June 30, 2030

Study information

• Verified date: November 2023
• Source: University of Alexandria
• Contact: Ahmad M Eweida, MD, PhD
• Phone: 0049 017665232331
• Email: ahmad.eweida[@]alexmed.edu.eg
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Mandibular reconstruction is necessary following trauma, tumour resections and extensive infections resulting in severe defects of the mandibular arch. For reconstructing large and recurrent defects, the vascularized free flaps are currently regarded as the gold standard. The use of these flaps, however, presents several major inconveniences. Although regenerative medicine in the field of cranio-maxillofacial reconstruction has now become a common practice, the main technical challenge is still related to vascularization of the regenerated tissue in large defects. Axial vascularization of constructs using a microvascular arteriovenous fistula/loop (AV loop) aims at providing the construct with blood supply through a defined and dedicated vascular axis. This technique was successfully demonstrated in some case reports, but was never applied in the craniofacial region. The current study aims to apply and assess the technique of axial vascularization using the AV loop of a bone substitute to reconstruct mandibular defects.

Description:

Background:

Mandibular reconstruction is necessary following tumour resections, infections or trauma resulting in severe defects of mandibular arch continuity and sacrifice of teeth. Basic reconstruction involves the use of non-vascularized bone grafts together with restoration of lost teeth by means of dental implants and implant-supported prostheses. Smaller bony defects (<6 cm) are commonly treated with nonvascularized corticocancellous grafts harvested from the anterior or posterior iliac crest. (Goh et al. 2008) For reconstructing larger and recurrent defects, currently the vascularized free flaps are regarded as the "gold standard". The use of these flaps, however, presents several major inconveniences. Harvesting of autologous tissue may result in a significant donor site morbidity, the extent of which may vary, according to the donor site and possibly according to the intervention technique. The problems include bleeding, pain, infections, donor site fractures and prolonged hospital stay. (Hartman et al. 2002; Rogers et al. 2003) The field of Regenerative Medicine promises new alternatives to surgical reconstruction through harnessing the regenerative capacity of the human body to repair itself. In the last few decades the rapid expansion of knowledge about the biological basis of wound healing and the role of cells, signals, and biological scaffolds has drawn the attention from ''tissue reconstruction'' to ''tissue regeneration''. New strategies started to emerge aiming at mimicking the normal healing process in regenerating lost or damaged tissues. The term "tissue engineering" was officially coined at a National Science Foundation workshop in 1988 to mean "the application of principles and methods of engineering and life sciences toward fundamental understanding of structure-function relationships in normal and pathological mammalian tissues and the development of biological substitutes to restore, maintain or improve tissue function".

Tissue engineering and Regenerative medicine depend on the presence of a biomaterial promoting cell growth and proliferation. In order to populate this biomaterial (scaffold) with new tissue, the body must effectively interact with this biomaterial. This necessitates the establishment of an early and reliable angiogenic response leading to the development of an adequate blood supply for the restoration of structure and function. (Hodde 2002) The three main components required for regeneration are the cells, scaffolds, and induction molecules. When growing tissues in vitro (Tissue Engineering), all three components should exist, however, when referring to Regenerative Medicine, any of these can be provided to the body in an attempt to optimize its capacity for regenerating its own tissues. Adding cells or growth factors to the biomaterials can reinforce tissue regeneration (Pellegrini et al. 2009), but the vascularization, and thus the integration, of theses biomaterials is still considered the determining issue in the success of any critical size defect regeneration. (Novosel et al. 2011) Applying principles of regenerative medicine in the field of cranio-maxillofacial reconstruction has now become a daily practice. The wide spectrum of applications ranges from simple addition of bioactive bone fillers to much more sophisticated techniques for bone replacement and reconstruction. The indications included reconstruction after minor developmental defects, trauma, infections, benign cysts or tumours but seldom following malignant tumour excision. (Clokie and Sandor 2008; Schuckert et al. 2009; Trautvetter et al. 2011) Warnke et al (Warnke et al. 2004), who used a completely different technique than those used in the previous case reports, reported the only case of regeneration after cancer ablation. The main technical difference was related to vascularization of the regenerated tissue. While all the reported cases for mandibular regeneration used the conventional extrinsic vascularization strategy, where the constructs were left to acquire a parasitic blood supply form the recipient site of implantation, Warnke et al (Warnke et al. 2004) used an axial vascularization strategy through a prelamination procedure in the Latissimus dorsi (LD) muscle followed by free tissue transfer of the regenerated mandible. Although this technique avoided bony donor site morbidities, the need to harvest the LD muscle represented a major drawback of this prelamination technique. This single case report highlighted the need for an efficiently vascularized construct if the regenerative therapy is to be applied for larger and recurrent defects.

Axial vascularization of scaffolds aims at providing the construct with blood supply through a defined and dedicated vascular axis. In this context, the blood supply of the construct is not randomly acquired from the implantation site, and thus the implantation in an area of low vascularization potential, as in irradiated or fibrosed surgical sites could be possible (Kneser et al. 2006). The two major techniques for axial vascularization are prelamination and prefabrication.

Prefabrication of a tissue construct is simply done by implanting an arterio-venous fistula or loop (AVL) or a vascular pedicle underneath or within the construct. This results in spontaneous sprouting of vessels from the loop or pedicle and subsequent revascularization of the whole tissue construct (Erol and Spira 1979; Guo and Pribaz 2009). Prelamination is another technique introduced by Pribaz and Fine (Pribaz and Fine 1994) in 1994 where the implantation of a construct into a vascularized territory (flap) is performed to create a customized vascularized unit. The end result of both techniques is an axially vascularized unit that depends for its nourishment upon a defined vascular axis.

Two more important terms to mention in this context are ''intrinsic'' and ''extrinsic'' vascularization modes. The extrinsic vascularization of a construct denotes acquiring its blood supply from the periphery towards the centre, while the intrinsic vascularization mode denotes that the core region of the construct is being vascularized first (Lokmic and Mitchell 2008). Accordingly, prefabrication is considered an intrinsic axial vascularization strategy. The construct in prelamination, however, is extrinsically vascularized within an intrinsically vascularized territory (Eweida et al. 2012).

As the reconstruction of challenging or irradiated bone defects requires an axially vascularized tissue bulk, applying the prelamination strategy will always end up in a remarkable donor site morbidity where the whole vascularized territory (mostly a muscle flap) should be transferred to the recipient site (Mesimaki et al. 2009; Warnke et al. 2004). The prefabrication technique, however, when applied to a tissue construct, entails only the transfer of this construct with its pedicle, thus diminishing the donor site morbidity to the minimal. Moreover, the prefabrication technique could be applied at the recipient site as a primary reconstruction technique, abolishing the donor site morbidity completely (Eweida et al. 2014; Horch et al. 2014).

One of the most extensively investigated techniques to induce axial vascularization in the tissue constructs is the arterio-venous loop or fistula (Arkudas et al. 2013; Horch et al. 2012) and its superiority over the vascular bundle in terms of vascular density and tissue regeneration potential was clearly demonstrated (Tanaka et al. 2003).

Preclinical data:

The first documented idea for axial vascularization using the AV loop was described by Erol and Spira (Erol and Spira 1979) in 1979 in a rat model. Morrison et al further developed the model and inserted the loop into isolation chambers (Hofer et al. 2003). They successfully demonstrated the induction of vascularization in polymer and gel matrices (Cassell et al. 2001). Since 2006, the design and characterization of the isolation chambers and the inset of the AV loop were further developed by the work of Horch et al (Kneser et al. 2006) where the engineering of vascularized transplantable bone was first successfully demonstrated by this research group. After successful evaluation of axial vascularisation in different bone substitutes, the concept was translated from the rat model to a large animal model (sheep) (Beier et al. 2011; Boos et al. 2012). Based on that model, axial vascularization was induced in constructs made of processed bovine cancellous bone substitutes and ß-TCP/HA (Tricalcium-phosphate/ hydroxyapatite) scaffolds. The sheep AV loop showed similar vascularization patterns like that of the rat but the optimum vascularization density was reached after a longer duration (8-12 weeks versus 4 weeks respectively) (Boos et al. 2011). Induction of new bone formation in the axially vascularized sheep isolation chamber was then demonstrated through implantation of MSC (Mesenchymal Stem Cells) in combination with osteogenic growth factor BMP based on a clinically applicable ß-TCP/HA bone substitute (Boos et al. 2013).

In 2011 the investigators introduced the AV Loop model for the first time for mandibular reconstruction in goats (Eweida et al. 2012; Eweida et al. 2011). The investigators could demonstrate successful regeneration of critical size marginal mandibular defects through axial vascularization of ßTCP/HA scaffolds charged with BMP (Bone morphogenic protein). The technique was discussed previously in details (Eweida et al. 2014; Eweida et al. 2012; Eweida et al. 2011). Briefly, a critical size (3 x 2 cm) marginal defect was created at the angle of the goat mandible. An equivalent sized scaffold made of ßTCP/HA was grooved to accommodate the AV Loop created by direct anastomosis of locally available vessels under the operative microscope. The scaffold was then mounted on a titanium plate and fixed to the mandible. Through our comparative studies between the AV Loop and the non-AV loop constructs, the axially vascularized constructs showed significantly more central vascularization and markedly enhanced central bone formation. The biomechanical characteristics were remarkably enhanced as well. The safety and efficacy of the model at a preclinical level was successfully demonstrated along a 6 months follow-up period (Eweida et al. 2014).

Clinical data to date:

Only two previous studies represented case reports of craniofacial bone regeneration using axially vascularized bone substitutes (non-randomised vascularization). The first study was published in 2004 by Warnke et al (Warnke et al. 2004) and further evaluated in 2006 (Warnke et al. 2006). The authors used a prelamination technique in the LD muscle of bovine mineral blocks (BioOss) to reconstruct of a large mandibular defect. The defect was reconstructed 8 years following subtotal mandibulectomy and irradiation. The construct was charged with BMP and autogenous bone marrow aspirate from the iliac crest. Although this prelamination strategy for mandibular regeneration has shown some promising initial results, the long-term results were not free of complications.

The second report was published in 2009 by Mesimaki et al (Mesimaki et al. 2009) who reported a similar prelamination technique for vascularizing a bone substitute made of ß-TCP (beta Tricalcium phosphate) in the rectus abdominis muscle. The vascularized construct was used to reconstruct a complex maxillary defect following hemi-maxillectomy due to a large keratocyst. An extensive review of literature (up to 06.2019) has shown that the prefabrication using the AV loop was never used for bone regeneration within the craniofacial region.

The introduced technique of axial vascularization of bone substitutes, however, was successfully demonstrated in humans. A case report was presented by Horch et al who have demonstrated successful bone regeneration and in situ axial vascularization using the AV loop model in two patients with bony defects in the radius and the tibia (Horch et al. 2014). Horch et al have demonstrated a safe and successful technique, encouraging results, and a complication-frees follow up period of 72 months.

Aim:

Applying and assessment of the technique of axial vascularization of a bone substitute using the arteriovenous loop (AVL) to reconstruct a mandibular defect

Patients and Methods:

Ten patients will be included in this prospective study.

Informed consent:

The patients will be fully oriented through a documented written informed consent in Arabic language. The informed written consent will include the following points:

• The procedure is related to research (Application of this technique in the craniofacial region)

• The purpose of this research.

• Alternative methods for mandibular reconstruction.

• The technical details of the procedure.

• The advantages and disadvantages of the technique.

• The risks of the procedure.

• The possible peri- and postoperative side effects.

• The management plan for the possible side effects.

• A statement that participation is voluntary, refusal to participate will involve no penalty or loss of benefits to which the patient is otherwise entitled, and the patient may discontinue participation at any time without penalty or loss of benefits, to which the subject is otherwise entitled

• An explanation of whom to contact for answers to questions about the procedure and patient's rights, and whom to contact in the event of research-related injury to the patient.

Preoperative assessment:

The patient will be subject to thorough history taking and full medical examinations.

Investigations will include:

• Routine laboratory work-up (Coagulation profile, fasting blood sugar, serum creatinine, blood urea, Complete Blood Count)

• Panoramic x-ray view of the mandible

• Computerized tomographic angiography (CTA) of the head and neck region.

• Three-dimensional printing of the mandible and the defect to facilitate preoperative orientation, plate and mesh pre-bending

Surgical procedures:

The procedure will be done under general anaesthesia in a supine position. Through a submandibular skin incision, the mandible will be exposed. The defect will be refreshed through bone curettage. The preformed reconstruction plate will be fixed to the mandible and traversing the defect. A preformed U-shaped titanium mesh will be mounted to the mandible and fixed with screws. The ipsilateral facial artery and vein (or other available vascular axes in case of lack of the facial vascular axis) will be anastomosed using the operative microscope via a reversed vein graft to create an AV loop harvested from the forearm. The AV loop will be laid within the defect. The titanium mesh will be filled with a mixture of:

1. Silicated Hydroxylapatite granules (NanoBone® vial 1.2 ml, ARTOSS, Rostock, Germany).

2. Autogenous bone marrow aspirate from the iliac crest.

3. Bone morphogenic protein 2 (BMP 2- InductOs®, Medtronic BioPharma B.V., Tolochenaz, Switzerland) The submandibular wound closed in layers.

Follow up and Evaluation:

Close monitoring of the patient for the vital signs, patency of the AV loop (via hand Doppler) and possible perioperative complications. The patient will be discharged on the 3rd day postoperative. The patient will be followed up regularly every week for wound healing, patency of the AVL and possible postoperative complications. Serial X-ray (panoramic view) will be done monthly to monitor the new bone formation. CTA will be performed after 6 months.

According to the clinical and radiological findings further dental rehabilitation will be planned after complete healing of the defect (6-9 months postoperative). Bone biopsies from dental rehabilitation (bone drilling for implants) will be studied for bone quality and vascularization using the standard H&E staining after decalcification.

Qualitative and quantitative data from Panoramic X-rays, CTA, and histological analysis will be evaluated for:

1. Bone regeneration and density.

2. Vascularization of bone substitutes. Results will be tabulated and compared with literature.

Risk analysis:

After successful demonstration of the safety and efficacy of the ''AV loop vascularization technique'' at the preclinical and clinical levels, we believe it is time to start applying the technique for mandibular regeneration. This new application, however, will not be without challenges. A major concern would be the hemodynamic changes resulting from the AV fistula. Although a similar model was never reported in literature, reports of the use of a distal arteriovenous fistula provide evidence that a controlled fistula placed in a peripheral artery is well-tolerated, providing that the size of the fistula is less than 1 cm and the fistula accepts less than 20 percent of the cardiac output (Blaisdell et al. 1966; Eweida et al. 2013; Horch et al. 2014; Tukiainen et al. 2006). Regarding bone density and mineralization distal to an AV fistula, contradictory results are shown in literature ranging from an increase of bone growth (Vanderhoef et al. 1963) to decreased mineralization and augmented osteopenia (Muxi et al. 2009). These studies focused on the hemodynamics and its impact on bone growth distal to the fistula. The long-term consequences of an intraosseous fistula, however, were not adequately studied in literature.

An early throbbing sensation or hum would be expected due to the initial high flow. The long-term studies at the preclinical level, however, have shown that the vascular bed matures with time leading to dumping down of the direct arteriovenous jet (Polykandriotis et al. 2007; Polykandriotis et al. 2009).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10
• Est. completion date: June 30, 2030
• Est. primary completion date: June 30, 2029
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Patients requiring mandibular reconstruction for further dental rehabilitation

• Mandibular defect (marginal/segmental) equals or more than 6 cm in largest dimension

• Middle age adult (18-65 years)

• Radiologically and pathologically documented tumour free mandibular defect

Exclusion Criteria:

• Extremes of age (<18 or > 65 years)

• Associated uncontrolled chronic illness (Diabetes mellitus, Hypertension, Rheumatoid arthritis, collagen disease, Chronic obstructive pulmonary disease)

• Primary reconstruction of a mandibular defect after tumour excision

Related Conditions & MeSH terms

• Mandibular Deficiency
• Micrognathism

Intervention

Other:
• Surgical reconstruction of the mandible using an axially vascularized bone construct
Surgically reconstructing defects of the mandible using reconstruction plate and Titanium mesh filled with an artificial bone substitute to form a bone construct. This construct will be vascularized at the same operation using a vein graft from the forearm. The vein graft will be microsurgically connected to an artery and vein within the facial/neck region to provide a vascular supply to the construct (arterio venous loop)

Locations

Country	Name	City	State
Egypt	Faculty of Medicine, University of Alexandria	Alexandria

Sponsors (1)

Lead Sponsor	Collaborator
University of Alexandria

Country where clinical trial is conducted

Egypt, 

References & Publications (36)

Arkudas A, Balzer A, Buehrer G, Arnold I, Hoppe A, Detsch R, Newby P, Fey T, Greil P, Horch RE, Boccaccini AR, Kneser U. Evaluation of angiogenesis of bioactive glass in the arteriovenous loop model. Tissue Eng Part C Methods. 2013 Jun;19(6):479-86. doi: 10.1089/ten.TEC.2012.0572. Epub 2013 Jan 16. — View Citation

Beier JP, Hess A, Loew J, Heinrich J, Boos AM, Arkudas A, Polykandriotis E, Bleiziffer O, Horch RE, Kneser U. De novo generation of an axially vascularized processed bovine cancellous-bone substitute in the sheep arteriovenous-loop model. Eur Surg Res. 2011;46(3):148-55. doi: 10.1159/000324408. Epub 2011 Mar 4. — View Citation

Blaisdell FW, Lim RC Jr, Hall AD, Thomas AN. Revascularization of severely ischemic extremities with an arteriovenous fistula. Am J Surg. 1966 Aug;112(2):166-74. doi: 10.1016/0002-9610(66)90005-5. No abstract available. — View Citation

Boos AM, Loew JS, Deschler G, Arkudas A, Bleiziffer O, Gulle H, Dragu A, Kneser U, Horch RE, Beier JP. Directly auto-transplanted mesenchymal stem cells induce bone formation in a ceramic bone substitute in an ectopic sheep model. J Cell Mol Med. 2011 Jun;15(6):1364-78. doi: 10.1111/j.1582-4934.2010.01131.x. Epub 2010 Jul 15. — View Citation

Boos AM, Loew JS, Weigand A, Deschler G, Klumpp D, Arkudas A, Bleiziffer O, Gulle H, Kneser U, Horch RE, Beier JP. Engineering axially vascularized bone in the sheep arteriovenous-loop model. J Tissue Eng Regen Med. 2013 Aug;7(8):654-64. doi: 10.1002/term.1457. Epub 2012 Mar 22. — View Citation

Cassell OC, Morrison WA, Messina A, Penington AJ, Thompson EW, Stevens GW, Perera JM, Kleinman HK, Hurley JV, Romeo R, Knight KR. The influence of extracellular matrix on the generation of vascularized, engineered, transplantable tissue. Ann N Y Acad Sci. 2001 Nov;944:429-42. doi: 10.1111/j.1749-6632.2001.tb03853.x. — View Citation

Clokie CM, Sandor GK. Reconstruction of 10 major mandibular defects using bioimplants containing BMP-7. J Can Dent Assoc. 2008 Feb;74(1):67-72. — View Citation

Erol OO, Spira M. New capillary bed formation with a surgically constructed arteriovenous fistula. Surg Forum. 1979;30:530-1. No abstract available. — View Citation

Eweida AM, Lang W, Schmitz M, Horch RE. Salvage of a free radial forearm flap by creation of an arteriovenous fistula at the distal arterial pedicle. Microsurgery. 2013 Jul;33(5):391-5. doi: 10.1002/micr.22089. Epub 2013 May 2. — View Citation

Eweida AM, Nabawi AS, Abouarab M, Kayed M, Elhammady H, Etaby A, Khalil MR, Shawky MS, Kneser U, Horch RE, Nagy N, Marei MK. Enhancing mandibular bone regeneration and perfusion via axial vascularization of scaffolds. Clin Oral Investig. 2014 Jul;18(6):1671-8. doi: 10.1007/s00784-013-1143-8. Epub 2013 Nov 19. — View Citation

Eweida AM, Nabawi AS, Elhammady HA, Marei MK, Khalil MR, Shawky MS, Arkudas A, Beier JP, Unglaub F, Kneser U, Horch RE. Axially vascularized bone substitutes: a systematic review of literature and presentation of a novel model. Arch Orthop Trauma Surg. 2012 Sep;132(9):1353-62. doi: 10.1007/s00402-012-1550-3. Epub 2012 May 27. — View Citation

Eweida AM, Nabawi AS, Marei MK, Khalil MR, Elhammady HA. Correction: Mandibular reconstruction using an axially vascularized tissue-engineered construct. Ann Surg Innov Res. 2012 Jun 15;6(1):4. doi: 10.1186/1750-1164-6-4. No abstract available. — View Citation

Goh BT, Lee S, Tideman H, Stoelinga PJ. Mandibular reconstruction in adults: a review. Int J Oral Maxillofac Surg. 2008 Jul;37(7):597-605. doi: 10.1016/j.ijom.2008.03.002. Epub 2008 May 1. — View Citation

Guo L, Pribaz JJ. Clinical flap prefabrication. Plast Reconstr Surg. 2009 Dec;124(6 Suppl):e340-e350. doi: 10.1097/PRS.0b013e3181bcf094. — View Citation

Hartman EH, Spauwen PH, Jansen JA. Donor-site complications in vascularized bone flap surgery. J Invest Surg. 2002 Jul-Aug;15(4):185-97. doi: 10.1080/08941930290085967. — View Citation

Hodde J. Naturally occurring scaffolds for soft tissue repair and regeneration. Tissue Eng. 2002 Apr;8(2):295-308. doi: 10.1089/107632702753725058. — View Citation

Hofer SO, Knight KM, Cooper-White JJ, O'Connor AJ, Perera JM, Romeo-Meeuw R, Penington AJ, Knight KR, Morrison WA, Messina A. Increasing the volume of vascularized tissue formation in engineered constructs: an experimental study in rats. Plast Reconstr Surg. 2003 Mar;111(3):1186-92; discussion 1193-4. doi: 10.1097/01.PRS.0000046034.02158.EB. — View Citation

Horch RE, Beier JP, Kneser U, Arkudas A. Successful human long-term application of in situ bone tissue engineering. J Cell Mol Med. 2014 Jul;18(7):1478-85. doi: 10.1111/jcmm.12296. Epub 2014 May 6. — View Citation

Horch RE, Kneser U, Polykandriotis E, Schmidt VJ, Sun J, Arkudas A. Tissue engineering and regenerative medicine -where do we stand? J Cell Mol Med. 2012 Jun;16(6):1157-65. doi: 10.1111/j.1582-4934.2012.01564.x. — View Citation

Kneser U, Polykandriotis E, Ohnolz J, Heidner K, Grabinger L, Euler S, Amann KU, Hess A, Brune K, Greil P, Sturzl M, Horch RE. Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Eng. 2006 Jul;12(7):1721-31. doi: 10.1089/ten.2006.12.1721. — View Citation

Lokmic Z, Mitchell GM. Engineering the microcirculation. Tissue Eng Part B Rev. 2008 Mar;14(1):87-103. doi: 10.1089/teb.2007.0299. — View Citation

Mesimaki K, Lindroos B, Tornwall J, Mauno J, Lindqvist C, Kontio R, Miettinen S, Suuronen R. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Int J Oral Maxillofac Surg. 2009 Mar;38(3):201-9. doi: 10.1016/j.ijom.2009.01.001. Epub 2009 Jan 24. — View Citation

Muxi A, Torregrosa JV, Fuster D, Peris P, Vidal-Sicart S, Sola O, Domenech B, Martin G, Casellas J, Pons F. Arteriovenous fistula affects bone mineral density measurements in end-stage renal failure patients. Clin J Am Soc Nephrol. 2009 Sep;4(9):1494-1499. doi: 10.2215/CJN.01470209. — View Citation

Novosel EC, Kleinhans C, Kluger PJ. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):300-11. doi: 10.1016/j.addr.2011.03.004. Epub 2011 Mar 17. — View Citation

Pellegrini G, Seol YJ, Gruber R, Giannobile WV. Pre-clinical models for oral and periodontal reconstructive therapies. J Dent Res. 2009 Dec;88(12):1065-76. doi: 10.1177/0022034509349748. Epub 2009 Nov 3. — View Citation

Polykandriotis E, Arkudas A, Horch RE, Sturzl M, Kneser U. Autonomously vascularized cellular constructs in tissue engineering: opening a new perspective for biomedical science. J Cell Mol Med. 2007 Jan-Feb;11(1):6-20. doi: 10.1111/j.1582-4934.2007.00012.x. — View Citation

Polykandriotis E, Euler S, Arkudas A, Pryymachuk G, Beier JP, Greil P, Dragu A, Lametschwandtner A, Kneser U, Horch RE. Regression and persistence: remodelling in a tissue engineered axial vascular assembly. J Cell Mol Med. 2009 Oct;13(10):4166-75. doi: 10.1111/j.1582-4934.2009.00828.x. Epub 2009 Jun 23. — View Citation

Pribaz JJ, Fine NA. Prelamination: defining the prefabricated flap--a case report and review. Microsurgery. 1994;15(9):618-23. doi: 10.1002/micr.1920150903. — View Citation

Rogers SN, Lakshmiah SR, Narayan B, Lowe D, Brownson P, Brown JS, Vaughan ED. A comparison of the long-term morbidity following deep circumflex iliac and fibula free flaps for reconstruction following head and neck cancer. Plast Reconstr Surg. 2003 Nov;112(6):1517-25; discussion 1526-7. doi: 10.1097/01.PRS.0000082817.26407.86. — View Citation

Schuckert KH, Jopp S, Teoh SH. Mandibular defect reconstruction using three-dimensional polycaprolactone scaffold in combination with platelet-rich plasma and recombinant human bone morphogenetic protein-2: de novo synthesis of bone in a single case. Tissue Eng Part A. 2009 Mar;15(3):493-9. doi: 10.1089/ten.tea.2008.0033. — View Citation

Tanaka Y, Sung KC, Tsutsumi A, Ohba S, Ueda K, Morrison WA. Tissue engineering skin flaps: which vascular carrier, arteriovenous shunt loop or arteriovenous bundle, has more potential for angiogenesis and tissue generation? Plast Reconstr Surg. 2003 Nov;112(6):1636-44. doi: 10.1097/01.PRS.0000086140.49022.AB. — View Citation

Trautvetter W, Kaps C, Schmelzeisen R, Sauerbier S, Sittinger M. Tissue-engineered polymer-based periosteal bone grafts for maxillary sinus augmentation: five-year clinical results. J Oral Maxillofac Surg. 2011 Nov;69(11):2753-62. doi: 10.1016/j.joms.2011.02.096. Epub 2011 Jun 16. — View Citation

Tukiainen E, Laurila K, Kallio M, Lorenzetti F, Kantonen I, Lepantalo M. Internal arteriovenous fistula within a radial forearm flap--a novel technique to increase femorodistal bypass graft flow to the diabetic foot and flap covering ischaemic tissue loss. Eur J Vasc Endovasc Surg. 2006 Apr;31(4):423-30. doi: 10.1016/j.ejvs.2005.05.006. Epub 2006 Feb 7. — View Citation

VANDERHOEF PJ, KELLY PJ, JANES JM, PETERSON LF. GROWTH AND STRUCTURE OF BONE DISTAL TO AN ARTERIOVENOUS FISTULA: QUANTITATIVE ANALYSIS OF TETRACYCLINE-INDUCED TRANSVERSE GROWTH PATTERNS. J Bone Joint Surg Br. 1963 Aug;45:582-96. No abstract available. — View Citation

Warnke PH, Springer IN, Wiltfang J, Acil Y, Eufinger H, Wehmoller M, Russo PA, Bolte H, Sherry E, Behrens E, Terheyden H. Growth and transplantation of a custom vascularised bone graft in a man. Lancet. 2004 Aug 28-Sep 3;364(9436):766-70. doi: 10.1016/S0140-6736(04)16935-3. — View Citation

Warnke PH, Wiltfang J, Springer I, Acil Y, Bolte H, Kosmahl M, Russo PA, Sherry E, Lutzen U, Wolfart S, Terheyden H. Man as living bioreactor: fate of an exogenously prepared customized tissue-engineered mandible. Biomaterials. 2006 Jun;27(17):3163-7. doi: 10.1016/j.biomaterials.2006.01.050. Epub 2006 Feb 28. — View Citation

* Note: There are 36 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Radiological and histological evidence of bone formation in the mandibular defect	Radiological evidence of bone formation in the mandibular defect via CT scans. Histological evidence of bone formation via bone biopsies during the dental rehabilitation procedure (bone drilling for implants).	6-9 months
Secondary	Dental rehabilitation	Implantation of osteointegrated implants within the former defect	9 months